C SOINS LTD

Executive Summary

C SOINS LTD is a dormant private limited company with minimal financial activity and stable equity reflecting its share capital. It currently poses low solvency and liquidity risks due to its non-trading status and compliance with filing requirements. However, the lack of operational data and recent director change warrant further investigation to assess future business viability.

C SOINS LTD - Analysis Report

Company Number: 12441517

Analysis Date: 2025-07-20 19:16 UTC

1. Risk Rating: LOW
   Justification: C SOINS LTD is a dormant company with no recorded trading activity or financial transactions. It has maintained consistent net assets equal to its nominal share capital (£1,000) over multiple years, indicating no liabilities or operational financial risks at present.

2. Key Concerns:

• Dormant Status: The company is not currently trading, which means it is not generating revenue or cash flow, limiting its operational viability as an investment.
• Minimal Financial Data: Absence of turnover, liabilities, or assets data other than share capital restricts assessment of underlying financial health or future prospects.
• Director Changes: Recent change in director (February 2024) with limited information on strategic direction or plans post-dormancy.

3. Positive Indicators:

• Compliance: No overdue filings for accounts or confirmation statements, demonstrating good regulatory compliance and governance standards.
• Stable Equity: Share capital and net assets remain constant, with no signs of financial distress or liquidation processes.
• Clear Ownership: Persons with significant control are identified and registered, maintaining transparency.

4. Due Diligence Notes:

• Investigate the business strategy and timeline for activation from dormant status, including any planned trading activities or capital injections.
• Review any off-balance sheet commitments or contingent liabilities not evident in dormant accounts.
• Confirm the background and intentions of the newly appointed director, Marc Pszczola, to understand future operational or financial plans.
• Verify absence of any regulatory or legal issues beyond Companies House filings, including director conduct records.